Dr. Jeremy Phillip Harris, MD

Dr. Harris practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Harris' NPI, 1922427053, was assigned on April 16, 2014. Dr. Harris graduated from Stanford University School Of Medicine in 2013. Dr. Harris holds California license A137804.

Dr. Harris' primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Harris' primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harris practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Harris' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Harris is board certified in radiation oncology by the American Board of Radiology. Dr. Harris is licensed in California.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, head & neck cancer radiation, lung cancer radiation, lymphoma radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Harris treats.

CMS data shows 1,987 Medicare services from Dr. Harris across 19 procedure codes in 2024, for 219 Medicare patients. Medicare paid $150,528 for them.

CMS counts 219 Medicare patients who saw Dr. Harris in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harris' median patient age at 67, with 44% women.

In 2024, Dr. Harris wrote 41 Medicare Part D claims for 26 patients. 98% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $412 in total drug cost. In 2022, CMS named 37 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Harris for performance year 2024, reported through an alternative payment model (APM). Dr. Harris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harris as offering telehealth.

Dmand AI links 48 papers to Dr. Harris, published from 2006 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Carcinoma, Squamous Cell, Lung Neoplasms and Carcinoma, Non-Small-Cell Lung. Dr. Harris has published most often in Int J Radiat Oncol Biol Phys. Dr. Harris' most frequent co-authors are Erqi Liu Pollom, Steven Neema Seyedin, MD and Eric Chau-Yong Ku, MD.

CMS Open Payments shows 9 general payments to Dr. Harris from 1 drug or device company from 2020 to 2023. Honoraria make up the largest share, 79% of the total. Novocure Inc. paid the most, $5,309.

Dr. Harris graduated from Stanford University School Of Medicine in 2013.

Dr. Harris is in network with 10 carriers, including Aetna, United Healthcare and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.